Use of Targeted Therapies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement From China, Japan, Taiwan, Korea, and Australia-Reference-Cited by-同舟云学术

Use of Targeted Therapies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement From China, Japan, Taiwan, Korea, and Australia

Published:2014-08 Issue:4 Volume:12 Page:225-233
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Ye Dingwei,Eto Masatoshi,Chung Jin Soo,Kimura Go,Chang Wen-Cheng,Chang Yen-Hwa,Pang See-Tong,Lee Jae Lyun,Niu Yuanjie,Gurney Howard,Uemura Hirotsugu

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. Epidemiology and risk factors for kidney cancer;Chow;Nat Rev Urol,2010

2. The epidemiology of renal cell carcinoma;Ljungberg;Eur Urol,2011

3. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival;Shi Stafford;J Urol,2008

4. Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma;Tsuchiya;Anticancer Drugs,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular modeling study combined with deep learning approach for the identification of potent β-catenin inhibitors;Research Journal of Biotechnology;2023-09-15

2. Risk Factors of Renal Cell Carcinoma;Medical Diagnosis;2023

3. A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data;International Journal of Clinical Oncology;2020-06-09

4. PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas;Journal of Clinical Pathology;2020-01-24

5. Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up;Japanese Journal of Clinical Oncology;2019-10-21